AI startups that raised at aggressive valuations during the 2021–2022 capital surge are now running into a hard M&A reality: buyers are not paying for historic fundraising marks, and many exit processes are stalling before they even begin. The issue isn’t weak technology or shrinking markets. It’s the persistent belief among founders and early investors that a previous round price represents a baseline for negotiations, even when commercial traction hasn’t caught up. That mindset is colliding directly with how strategic acquirers evaluate deals today.
Corporate buyers operate on a fundamentally different framework. They price on evidence — recurring revenue quality, predictable growth, defensible IP, customer concentration, and the ease of integrating a product into an existing roadmap. Potential is a secondary factor. Meanwhile, many AI founders still treat their last valuation as a proxy for enterprise value, assuming that any exit must clear that bar. The result is a structural mismatch: sellers negotiating from a theoretical future, buyers underwriting a present-day business. This expectation gap alone is enough to kill otherwise sensible transactions.
The confusion is reinforced by a handful of headline-grabbing outliers. Deals like Inflection AI’s reported $650 million acquisition by Microsoft are widely referenced but rarely relevant. Those transactions are unique combinations of talent, strategic urgency, and corporate budgets that only a few buyers in the world can deploy. For the vast majority of AI startups, they do not represent a pricing benchmark — they represent exceptions that distort judgment. Expecting a standard M&A process to resemble those deals is the fastest way to misread the market.
For investors, the critical insight is straightforward: misaligned valuation expectations are a more dangerous threat to exits than competitive pressure or technology gaps. When sellers anchor on fundraising-era prices, serious buyers disengage early because there is no credible path to price discovery. Months are lost, momentum fades, and internal teams grow distracted while the company attempts to chase numbers that were never connected to operational performance in the first place.
The path forward requires a shift in mindset for portfolio companies caught in this trap. Exits must be framed around what current traction justifies, not what the cap table implies. When founders recalibrate around revenue quality, product maturity, and verifiable market demand, productive conversations with buyers reopen. Without that reset, the valuation expectation gap will remain the quiet deal killer behind a growing number of failed AI M&A processes.
